StockViz
RANKINGS
CVRx, Inc.
NasdaqGS:CVRX
Sector
Location
Market Cap
USD 191.63 M
Share Price
USD 7.35
Avg Daily Volume
361,050
Change (1 day)
7.61%
Change (1 year)
-24.38%
Change (YTD)
-41.99%
CVRx, Inc. Cash Flow Statement 2020 - 2025
This table shows the Cash Flow Statement for CVRx, Inc. going from 2020 until 2025. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%
Edwards Lifesciences Corporation
USD 78.28
EW
+0.23
0.29%
GE HealthCare Technologies Inc.
USD 74.45
GEHC
-0.68
-0.91%
DexCom, Inc.
USD 85.33
DXCM
+1.96
2.35%
Natera, Inc.
USD 158.18
NTRA
-2.25
-1.40%
Laboratory Corporation of America Holdings
USD 249.80
LH
+0.18
0.07%
Baxter International Inc.
USD 28.53
BAX
-0.17
-0.59%
Hologic, Inc.
USD 64.62
HOLX
-1.10
-1.67%
Fisher & Paykel Healthcare Corporation Limited
USD 21.23
FPH.NZ
-0.21
-0.97%
Exact Sciences Corporation
USD 54.30
EXAS
+2.39
4.60%
Penumbra, Inc.
USD 239.32
PEN
+1.38
0.58%
ConvaTec Group Plc
USD 3.48
CTEC.L
-0.04
-1.11%
Hangzhou Tigermed Consulting Co., Ltd.
USD 5.94
3347.HK
-0.24
-3.88%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.64
300832.SZ
-0.06
-0.75%
APT Medical Inc.
USD 40.76
688617.SS
-0.38
-0.93%
Lantheus Holdings, Inc.
USD 83.06
LNTH
+1.75
2.15%
DiaSorin S.p.A.
USD 105.58
DIA.MI
-0.36
-0.34%
Carl Zeiss Meditec AG
USD 60.25
AFX.DE
-0.59
-0.97%
Teleflex Incorporated
USD 115.75
TFX
-0.65
-0.56%